Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma × Dosage Forms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Leukemia 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Vomiting 1 Substance-Related Disorders 1 Solid Tumors 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Follicular 1 Lymphoma 1 Low Anterior Resection Syndrome 1 Colonic Neoplasms 1 Acromegaly 1

Interventions

Cyclophosphamide 238 Rituximab 213 Etoposide 137 Filgrastim 130 Vincristine 119 Doxorubicin 114 Prednisone 95 Radiotherapy 90 Cytarabine 87 Peripheral Blood Stem Cell Transplantation 72 Methotrexate 71 fludarabine phosphate 68 Melphalan 68 Busulfan 60 Dexamethasone 49 Granulocyte Colony-Stimulating Factor 46 Carmustine 44 fludarabine 41 Bortezomib 35 Ifosfamide 34 Tacrolimus 33 Whole-Body Irradiation 32 Leucovorin 31 Gemcitabine 31 Antilymphocyte Serum 31 Mycophenolic Acid 30 Methylprednisolone 27 Cyclosporine 27 Bendamustine Hydrochloride 27 sargramostim 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03593187 2025-11-20

GENHIV

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡